US Patent Class 930
PEPTIDE OR PROTEIN SEQUENCE
 Electronic File Wrappers |  Electronic Patent Documents |  Paper Patent Documents | Current as of: June, 1999
|  and Services |
| Electronic File Wrappers | Electronic Patent Documents | Paper Patent Documents | Current as of: June, 1999
| and Services |
| DF | CLASS NOTES | |
| ****************************** | ||
| CROSS-REFERENCE ART COLLECTIONS 10-320 | ||
| ****************************** | ||
| 10 | DF | PEPTIDE OR PROTEIN SEQUENCE |
| 20 | DF | .~ Containing modified or unusual amino acid (See note 1 and note 2) |
| 21 | DF | .~.~ Containing D-amino acid |
| 22 | DF | .~.~ Containing radioactive atom (See note 3) |
| 23 | DF | .~.~ Containing halogen (See note 3) |
| 24 | DF | .~.~ Containing sulfur (See note 4) |
| 25 | DF | .~.~ Containing heavy metal or salt thereof |
| 30 | DF | .~ Linear peptide or protein containing a nonpeptide or abnormal peptide link (See note 5) |
| 31 | DF | .~.~ Retro-inverted |
| 40 | DF | .~ Angiotensin; related peptides |
| 50 | DF | .~ Atrial or brain natriuretic peptide; related peptides |
| 60 | DF | .~ Calcitonin; related peptides |
| 70 | DF | .~ Corticotropin; related peptides |
| 80 | DF | .~ Endorphin or Enkephalin; related peptides |
| 90 | DF | .~ Erythropoietin; related peptides |
| 100 | DF | .~ Factor VIII, AHF; related peptides |
| 110 | DF | .~ Gonadotropin; related peptides |
| 120 | DF | .~ Growth hormone, growth factor other than T-cell or B-cell growth factor, and growth hormone releasing factor; related peptides |
| 130 | DF | .~ Luteinizing hormone-releasing hormone (LH-RH); related peptides |
| 140 | DF | .~ Lymphokine; related peptides |
| 141 | DF | .~.~ Interleukin |
| 142 | DF | .~.~ Interferon |
| 143 | DF | .~.~ Lymphotoxin |
| 144 | DF | .~.~ Tumor necrosis factor |
| 145 | DF | .~.~ Colony stimulating factor |
| 150 | DF | .~ Oxytocin or vasopressin; related peptides |
| 160 | DF | .~ Somatostatin; related peptides |
| 170 | DF | .~ Vasoactive intestinal peptides; related peptides |
| 180 | DF | .~ Thymus derived hormone or factor; related peptides |
| 190 | DF | .~ Antibiotic |
| 200 | DF | .~ Bacterial peptide or bacterial protein (See note 6) |
| 210 | DF | .~ Parasitic peptide or parasitic protein (See note 6) |
| 220 | DF | .~ Viral peptide or viral protein (See note 6) |
| 221 | DF | .~.~ Retrovirus related, or human immunodeficiency virus related, or simian immunodeficiency virus related |
| 222 | DF | .~.~ Foot and mouth disease related |
| 223 | DF | .~.~ Hepatitis related |
| 224 | DF | .~.~ Herpes related |
| 230 | DF | .~ Multicellular plant peptide or multicellular plant protein |
| 240 | DF | .~ Enzyme or isoenzyme |
| 250 | DF | .~ Enzyme inhibitor |
| 260 | DF | .~ Containing Cys-Cys disulfide bridge between nonadjacent cysteine residues (See note 7) |
| 270 | DF | .~ Cyclic peptide or cyclic protein (See note 8) |
| 280 | DF | .~ Bound to a nonpeptide drug, nonpeptide label, nonpeptide carrier, or a nonpeptide resin |
| 290 | DF | .~ Polyamino acid or polypeptide with an uninterrupted series of peptide repeating units |
| 300 | DF | .~ Signal or leader sequence |
| 310 | DF | .~ Linker sequence |
| 320 | DF | .~ Modification to prevent enzymatic degradation (See note 9) |
| ****************************** | ||
| DIGESTS | ||
| ****************************** | ||
| DIG 500 | DD | PEPTIDES CONTAINING SACCHARIDE RADICALS AND HAVING A FULLY DEFINED SEQUENCE OF AMINO ACIDS AND WHEREIN THE PEPTIDE SEQUENCE IS NOT PART OF A RING STRUCTURE, E.G., BLEOMYCIN, PHLEOMYCIN, MURAMYLPEPTIDES, ETC., (C07K-9/00D, 9/00D2, 9/00D4, 9/00D9) |
| DIG 510 | DD | PEPTIDES CONTAINING SACCHRIDE RADICALS AND HAVING A FULLY DEFINED SEQUENCE OF AMINO ACIDS WHEREIN THE PEPTIDE SEQUENCE IS PART OF A RING STRUCTURE AND IS DIRECTLY ATTACHED TO A HETERO ATOM OF THE SACCHARIDE ATOM, E.G., ACTAPLANIN, AVOPARCIN, RISTOMYCIN, VANCOMYCIN, ETC., (C07K 9/00F2) |
| DIG 520 | DD | PEPTIDES CONTAINING SACCHARIDE RADICALS AND HAVING A FULLY DEFINED SEQUENCE OF AMINO ACIDS WHEREIN THE PEPTIDE SEQUENCE IS PART OF A RING STRUCTURE AND IS NOT DIRECTLY ATTACHED TO A HETERO ATOM OF THE SACCHARIDE ATOM (C07K-9/00F4) |
| DIG 530 | DD | PROTEINS HAVING A FULLY DEFINED SEQUENCE OF AMINO ACIDS OR DERIVATIVES THEREOF, I.E., MORE THAN 100 AMINO ACIDS (C07K-13/00) |
| DIG 532 | DD | CYCLIC PEPTIDES DERIVED FROM AT LEAST FIVE AMINO ACIDS AND CONTAINING AT LEAST ONE ABNORMAL PEPTIDE LINK (C07K-7/50) |
| DIG 533 | DD | .~ With only normal peptide links in the ring (C07K-7/52) |
| DIG 534 | DD | .~.~ With all amino acids in L-form (C07K-7/52A) |
| DIG 535 | DD | .~.~ With at least one amino acid in D-form (C07K-7/52B) |
| DIG 536 | DD | .~ With at least one abnormal peptide link in the ring (C07K-7/54) |
| DIG 537 | DD | .~.~ The cyclisation not occurring through the 2,4-diamino-butanoic acid (C07K-7/56) |
| DIG 538 | DD | .~.~.~ Bacitracins; related peptides (C07K-7/58) |
| DIG 539 | DD | .~.~.~.~ With all amino acids in L-form (C07K-7/58A) |
| DIG 541 | DD | .~.~.~.~ With at least one amino acid in D-form (C07K-7/58B) |
| DIG 542 | DD | .~.~ The cyclisation occurring through the 4-amino group of the 2,4-diamino butanoic acid (C07K-7/60) |
| DIG 543 | DD | .~.~.~ Polymyxins; related peptides (C07K-7/62) |
| DIG 544 | DD | .~.~.~.~ With all amino acids in L-form (C07K-7/62A) |
| DIG 545 | DD | .~.~.~.~ With at least one amino acid in D-form (C07K-7/62B) |
| DIG 546 | DD | CYCLIC PEPTIDES DERIVED FROM AT LEAST FIVE AMINO ACIDS AND CONTAINING ONLY NORMAL PEPTIDE LINKS (C07K-7/64) |
| DIG 547 | DD | .~ Gramicidins S, C; Tyrocidins A, B, C; related peptides (C07K-7/66) |
| DIG 548 | DD | .~.~ With all amino acids in L-form (C07K-7/66A) |
| DIG 549 | DD | .~.~ With at least one amino acid in D-form (C07K-7/66B) |
| DIG 550 | DD | PEPTIDES CONTAINING THE SEQUENCE (A-Leu-Glu-Ile-Lys-Orn-Ile-Phe-His-Asp-Asp NH2), A BEING H OR Ile-Cys, E.G., BACITRACINS A OR F OR RELATED PEPTIDES (C07K-99/00B) |
| DIG 551 | DD | .~ With all amino acids in L-form (C07K-99/00B1) |
| DIG 552 | DD | .~ With at least one amino acid in D-form (C07K-99/00B2) |
| DIG 553 | DD | PEPTIDES CONTAINING THE C-TERMINAL SEQUENCE (X-Cys-Phe-Gly-Phe-Gly-Gly Arg-A-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Y) WITH X BEING NH, Y BEING -OH, NH, OR PART OF THE SEQUENCE -Asn-Ser-Phe-Arg-Tyr-Arg-Arg- AND A BEING Met OR Ile, E.G., ATRIOPEPTINE; ATRIAL NATRIURETIC PEPTIDES AND PROTEINS (ANP) (C07K-99/00C) |
| DIG 554 | DD | .~ With all amino acids in L-form (C07K-99/00C1) |
| DIG 555 | DD | .~ With at least one amino acid in D-form (C07K-99/00C2) |
| DIG 556 | DD | PEPTIDES CONTAINING THE SEQUENCE (Asp-Pro-A-Tyr-B-C-Val-Ser-Asn-Ala-Asp-Leu Met-Asp- Phe-Lys-Asn-Leu-Leu-Y), WITH A, B, C BEING AMINO ACIDS, AND Y BEING A PEPTIDE SEQUENCE, E.G., CARDIODILATIN (SEE SUBCLASS 553 FOR PATENTS THAT CONTAIN THE AERIAL NATRIURETIC PEPTIDE SEQUENCE) (C07K-99/00D) |
| DIG 557 | DD | .~ With all amino acids in L-form (C07K-99/00D1) |
| DIG 558 | DD | .~ With at least one amino acid in D-form (C07K-99/00D2) |
| DIG 559 | DD | PEPTIDES CONTAINING THE SEQUENCE (Tyr-Ala-Asp-Ala-Ile-Phe-Tyr -Asn-Ser Tyr-Arg-Lys-Val -Leu-Gly-Gln-Leu-Ser- Ala-Arg-Lys-Leu-Leu- Gln-Asp Ile-Met-A-Arg- Gln-Gln-Gly-Glu-B-Asn- Gln-Glu-C-Gly- -Ala-D-E Arg-Leu-NH) WITH A BEING Ser OR Asn, B BEING Ser OR Arg, C BEING Arg OR Gln, D BEING Arg OR Lys, AND E BEING Ala, Val, OR Phe, E.G., SOMATOLIBERIN (GONADOTROPIN RELEASING FACTOR) (C07K-99/00F) |
| DIG 560 | DD | PEPTIDES CONTAINING THE SEQUENCE (Tyr-D-Ala-Phe-Gly-Tyr -Pro-Ser), E.G., DERMORPHIN (C07K-99/00H) |
| DIG 565 | DD | PEPTIDES CONTAINING THE SEQUENCE (Cys-Tyr-A-Gln-Asn-Cys-Pro-B -Gly NH2), WITH A BEING Ile OR Phe, B BEING Leu OR Arg OR Lys OR S-S BRIDGE 1-6, E.G., OXYTOCIN, VASOPRESSIN, OR A RELATED PEPTIDE (C07K 99/02) |
| DIG 566 | DD | .~ With all amino acids in L-form (C07K-99/02A) |
| DIG 567 | DD | .~ With at least one amino acid in D-form (C07K-99/04) |
| DIG 570 | DD | PEPTIDES CONTAINING THE SEQUENCE (Ser-Tyr-Ser-Met-Glu-His-Phe -Arg Trp-Gly-Lys-Pro-Val-Gly -Lys-Lys-Arg-Arg-Pro-Val-Lys -Val-Tyr-Pro Asp-Gly- A-B-C-D-E-Ala-Glu- Ala-Phe-Pro-Leu-Glu-Phe-OH), A-B-C-D-E BEING Glu-Ala-Glu-Asp-Ser- OR Ala-Glu-Asp-Glu-Leu OR Ala-Glu-Asp-Glu-Ser, E.G., CORTICOTROPIN (ACTH) OR RELATED PEPTIDES (C07K-99/06) |
| DIG 571 | DD | .~ With all amino acids in L-form (C07K-99/06A) |
| DIG 572 | DD | .~ With at least one amino acid in D-form (C07K-99/08) |
| DIG 580 | DD | PEPTIDES CONTAINING THE SEQUENCE (CH3CO-Ser-Tyr-Ser-Met-Glu -His-Phe Arg-Trp-Gly-Lys- Pro-Val-NH2), E.G., A-MSH, OR RELATED PEPTIDES (FRAGMENTS WHICH ARE COMMON WITH DIGEST 570 ARE ALSO IN THAT CLASSIFICATION) (C07K-99/10) |
| DIG 581 | DD | .~ With all amino acids in L-form (C07K-99/10A) |
| DIG 582 | DD | .~ With at least one amino acid in D-form (C07K-99/12) |
| DIG 590 | DD | PEPTIDES CONTAINING THE SEQUENCE (A-Arg-Val-Tyr-Val- Ile- His-Pro-Phe-B), A BEING Asp OR Asn, AND B BEING -OH OR His-Leu-OH, E.G., ANGIOTENSIN I, PEPSITENSIN, OR RELATED PEPTIDES (C07K-99/14) |
| DIG 591 | DD | .~ With all amino acids in L-form (C07K-99/14A) |
| DIG 592 | DD | .~ With at least one amino acid in D-form (C07K-99/16) |
| DIG 600 | DD | PEPTIDES CONTAINING THE SEQUENCE (A-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg OH), A BEING H OR Lys, E.G., KALLIDIN, BRADYKININ, ETC. OR RELATED PEPTIDES (C07K-99/18) |
| DIG 601 | DD | .~ With all amino acids in L-form (C07K-99/18A) |
| DIG 602 | DD | .~ With at least one amino acid in D-form (C07K-99/20) |
| DIG 610 | DD | PEPTIDES CONTAINING THE SEQUENCE (Pgl-Pro-Ser-Lys-Asp-Ala-Phe -Ile Gly-Leu-Met-NH2), E.G., ELEDOISIN, OR RELATED PEPTIDES (C07K-99/22) |
| DIG 611 | DD | .~ With all amino acids in L-form (C07K-99/22A) |
| DIG 612 | DD | .~ With at least one amino acid in D-form (C07K-99/24) |
| DIG 620 | DD | PEPTIDES CONTAINING THE SEQUENCE (Gly-Ile-Val-Glu-Gln-Cys-Cys -A-B-C Cys-Ser-Leu-Tyr-Gln -Leu-Glu-Asn-Tyr-Cys -Asn-PH) and (Phe-Val-Asn- Gln-His-Leu-Cys-Gly-Ser- His-Leu-Val-Glu-Ala-Leu- Tyr-Leu-Val-Cys Gly-Glu- Arg-Gly-Phe -Phe-Tyr-Tyr-Pro-Lys-D), A-B-C BEING -Ala-Ser Val-, OR -Ala-Gly-Val-, OR -Thr-Ser-Ile-, OR -Ala-Ser-Val-, D BEING Ala-OH OR Thr-OH, E.G., HUMAN INSULIN OR RELATED PEPTIDES (C07K-99/26) |
| DIG 621 | DD | .~ With all amino acids in L-form (C07K-99/26A) |
| DIG 622 | DD | .~ With at least one amino acid in D-form (C07K-99/28) |
| DIG 630 | DD | PEPTIDES CONTAINING THE SEQUENCE (Pgl-Gly-Pro-Trp-A-Glu-Glu- B-Glu-B Ala-Tyr- Gly-Trp-Met- Leu- Asp-Phe- Tyr- NH2, A BEING Met, Leu or Val, B BEING Glu OR Ala, E.G., GASTRIN OR RELATED PEPTIDES, ETC. (C07K 99/30) |
| DIG 631 | DD | .~ With all amino acids in L-form (C07K-99/30A) |
| DIG 632 | DD | .~ With at least one amino acid in D-form (C07K-99/32) |
| DIG 640 | DD | PEPTIDES CONTAINING THE SEQUENCE (His-Ser-Gln-Gly-Thr-Phe-Thr -Ser Asp-Tyr-Lys-Ser- Tyr-Leu-Asp-Ser-Arg-Arg-Ala -Gln-Asp-Phe-Val-Gln-Trp Leu- Met-Asn-Thr-OH), E.G., GLUCAGON OR RELATED PEPTIDES, ETC. (C07K-99/34) |
| DIG 641 | DD | .~ With all amino acids in L-form (C07K-99/34A) |
| DIG 642 | DD | .~ With at least one amino acid in D-form (C07K-99/36) |
| DIG 650 | DD | PEPTIDES CONTAINING THE SEQUENCE (His-Ser-Asp-Gly-Thr-Phe-Thr -Ser Glu-Leu-Ser-Arg-Leu-Arg -Asp-Ser-Ala-Arg-Leu-Gln-Arg -Leu-Leu-Gln Gly-Leu-Val-NH2), E.G., SECRETIN OR RELATED PEPTIDES, ETC. (FRAGMENTS CONTAINING THE UNCHANGED SEQUENCE 4-8, I.E., Gly-Thr-Phe-Thr-Ser ARE ALSO CLASSIFIED IN DIGEST 640) (C07K-99/38) |
| DIG 651 | DD | .~ With all amino acids in L-form (C07K-99/38A) |
| DIG 652 | DD | .~ With at least one amino acid in D-form (C07K-99/40) |
| DIG 660 | DD | PEPTIDES CONTAINING THE SQUENCE (Cys-Ser-Asn-Leu-Ser-Thr-Cys -Val Leu-Ser-Ala-Tyr-Trp-Arg -Asn-Leu-Asn-Asn-Phe-His -Arg-Phe-Ser-Gly-Met Gly- Phe-Gly-Pro-Glu-Thr-Pro-OH), E.G., A-THYROCALCITONIN, ETC., I.E., PORCINE OR RELATED PEPTIDES (C07K-99/42) |
| DIG 661 | DD | .~ With all amino acids in L-form (C07K-99/42A) |
| DIG 662 | DD | .~ With at least one amino acid in D-form (C07K-99/44) |
| DIG 670 | DD | PEPTIDES CONTAINING THE SEQUENCE (Cys-Gly-Asn-Leu-Ser-Thr-Cys -Met Leu-Gly-Thr-Tyr- Thr-Glu-Asp-Phe-Asn-Lys -Phe-His-Thr-Phe-Pro -Gln Thr-Ala-Ile-Gly- Val-Gly-Ala-Pro-OH), E.G., CALCITONIN M (HUMAN) OR RELATED PEPTIDES (FRAGMENTS WHICH ARE COMMON WITH DIGEST 660 ARE ALSO IN THAT CLASSIFICATION) (C07K-99/46) |
| DIG 671 | DD | .~ With all amino acids in L-form (C07K-99/46A) |
| DIG 672 | DD | .~ With at least one amino acid in D-form (C07K-99/48) |
| DIG 680 | DD | PEPTIDES CONTAINING THE SEQUENCE (HCO-Val- Ile- Gly-Ala-Leu-Ala-Val Val- Val-Trp-Leu-Trp- Phe- Leu-Trp-Leu-Trp-NHCH2CH2OH), E.G., GRAMICIDINS A OR B OR RELATED PEPTIDES (C07K-99/50) |
| DIG 681 | DD | .~ With all amino acids in L-form (C07K-99/50A) |
| DIG 682 | DD | .~ With at least one amino acid in D-form (C07K-99/52) |
| DIG 690 | DD | PEPTIDES CONTAINING THE SEQUENCE (Pgl-His-Trp-Ser-Tyr-Gly-Leu -Arg Pro-Gly-NH2), E.G., LH-RH, LRF, OR RELATED PEPTIDES (C07K-99/54) |
| DIG 691 | DD | .~ With all amino acids in L-form (C07K-99/54A) |
| DIG 692 | DD | .~.~ 1-Pgl, 10-Gly derivatives (C07K-99/54A1) |
| DIG 693 | DD | .~.~ Des-1-Pgl derivatives (C07K-99/54A2) |
| DIG 694 | DD | .~.~ Des-10-Gly derivatives (C07K-99/54A3) |
| DIG 695 | DD | .~ With at least one amino acid in D-form (C07K-99/56) |
| DIG 696 | DD | .~.~ 1-Pgl, 10-Gly derivatives (C07K-99/56A1) |
| DIG 697 | DD | .~.~ Des-1-Pgl derivatives (C07K-99/56A2) |
| DIG 698 | DD | .~.~ Des-10-Gly derivatives (C07K-99/56A3) |
| DIG 700 | DD | PEPTIDES CONTAINING THE SEQUENCE (Ala-Gly-Cys-Lys-Asn-Phe-Phe- Trp Lys-Thr-Phe-Thr -Ser-Cys-OH), E.G., SOMATOSTATIN, SRIF, OR RELATED PEPTIDES (C07K-99/58) |
| DIG 701 | DD | .~ All amino acids in L-form (C07K-99/58A) |
| DIG 702 | DD | .~.~ S-S bridge 3,14 being modified (for the reduced form Cys-3 or Cys-14 being modified) (C07K-99/58A1A) |
| DIG 703 | DD | .~.~.~ Modification at Cys-3 (C07K-99/58A1B) |
| DIG 704 | DD | .~.~.~ Modification at Cys-14 (C07K-99/58A1C) |
| DIG 705 | DD | .~.~.~ Modification at both Cys-3 and Cys-14 (C07K-99/58A1D) |
| DIG 706 | DD | .~ At least one amino acid in D-form (C07K-99/60) |
| DIG 707 | DD | .~.~ S-S bridge 3,14 being modified (for the reduced form Cys-3 or Cys-14 being modified) (C07K-99/A1) |
| DIG 708 | DD | .~.~.~ Modification at Cys-3 (C07K-99/60A1B) |
| DIG 709 | DD | .~.~.~ Modification at Cys-14 (C07K-99/60A1C) |
| DIG 710 | DD | .~.~.~ Modifications at both Cys-3 and Cys-14 (C07K-99/60A1D) |
| DIG 720 | DD | PEPTIDES CONTAINING THE SEQUENCE (Tyr-Gly-Gly-Phe-Met-Thr-Ser- Glu Lys-Ser-Gln-Thr-Pro- Leu-Val-Thr-Leu-Phe-Lys-Asn- Ala-Ile-Ile-Lys-Asn Ala-His- Lys-Lys-Gly-Glu-OH), E.G., B-ENDORPHIN OR RELATED PEPTIDES (C07K-99/62) |
| DIG 721 | DD | .~ With all amino acids in L-form (C07K-99/62A) |
| DIG 722 | DD | .~ With at least one amino acid in D-form (C07K-99/64) |
| DIG 730 | DD | PEPTIDES CONTAINING THE SEQUENCE (Tyr-Gly-Gly-Phe-Met-Thr-Ser- Glu Lys-Ser-Gln- Thr-Pro-Leu-Val-Thr-OH), E.G., LIPOTROPIN OR RELATED PEPTIDES (FRAGMENTS WHICH ARE COMMON WITH DIGEST 720 ARE ALSO IN THAT CLASSIFICATION) (C07K-99/66) |
| DIG 731 | DD | .~ With all amino acids in L-form (C07K-99/66A) |
| DIG 732 | DD | .~ With at least one amino acid in D-form (C07K-99/68) |
| DIG 740 | DD | PEPTIDES CONTAINING THE SEQUENCE (Try-Gly-Gly-Phe-X), X BEING AN AMINO ACID, E.G., ENKEPHALINS OR RELATED PEPTIDES (SEQUENCES CONTAINING MORE THAN FIVE AMINO ACIDS ARE CLASSIFIED IN DIGESTS 720 OR 730) (C07K 99/70) |
| DIG 741 | DD | .~ With all amino acids in L-form (C07K-99/70A) |
| DIG 742 | DD | .~ With at least one amino acid in D-form (C07K-99/72) |
| DIG 750 | DD | PEPTIDES CONTAINING THE SEQUENCE (Arg-Lys-Asp-Val-Tyr-Val-), E.G., THYMIN I OR II, THYMOPOIETINS, OR RELATED PEPTIDES (C07K-99/74) |
| DIG 751 | DD | .~ With all amino acids in L-form (C07K-99/74A) |
| DIG 752 | DD | .~ With at least one amino acid in D-form (C07K-99/76) |
| DIG 760 | DD | PEPTIDES CONTAINING THE SEQUENCE (Asp-A-Gly-Pro-Tyr-B-Met- Glu-His Phe-Arg-Trp-Gly- Ser-Pro-Pro-Lys-Asp-OH), A BEING Glu or Ser, B BEING Lys or Arg, E.G., B-MELANOTROPINS OR RELATED PEPTIDES (C07K-99/78) |
| DIG 761 | DD | .~ With all amino acids in L-form (C07K-99/78A) |
| DIG 762 | DD | .~ With at least one amino acid in D-form (C07K-99/80) |
| DIG 770 | DD | PEPTIDES CONTAINING THE SEQUENCE (Thr-Val-Pro-Ser- (N-Methyl)Val-) (C07K-99/82) |
| DIG 771 | DD | .~ With all amino acids in L-form (C07K-99/82A) |
| DIG 772 | DD | .~ With at least one amino acid in D-form (C07K-99/84) |
| DIG 780 | DD | TETRAPEPTIDES (DERIVED FROM ONLY FOUR AMINO ACIDS) (C07K-5/10) |
| DIG 781 | DD | .~ Contains at least one ring formed only through peptide links (C07K 5/12B) |
| DIG 782 | DD | .~ With at least one amino acid in D-form (C07K-5/10Z) |
| DIG 783 | DD | .~ The first amino acid being heterocyclic (Pro) (C07K-5/10H) |
| DIG 784 | DD | .~ The first amino acid contains the same number of amino and carboxylic acid or derivative groups (neutral) (C07K-5/10A) |
| DIG 785 | DD | .~.~ And aliphatic (C07K-5/10A1) |
| DIG 786 | DD | .~.~ And carbocyclic ring (Phe) (C07K-5/10A2) |
| DIG 787 | DD | .~ The first amino acid contains more amino groups than carboxylic acid or derivative groups (basic) (C07K-5/10B) |
| DIG 788 | DD | .~ The first amino acid contains more carboxylic acid or derivative groups than amino groups (acidic) (C07K-5/10C) |
| DIG 789 | DD | .~.~ Asp-X-Y-Z, Asn-X-Y-Z, or derivatives thereof, X, Y and Z being amino acids (C07K-5/10C1) |
| DIG 790 | DD | LINEAR PEPTIDES CONTAINING AT LEAST ONE ABNORMAL PEPTIDE LINK AND DERIVED FROM 5-100 AMINO ACIDS (C07K-7/02) |
| DIG 800 | DD | LINEAR PEPTIDES CONTAINING ONLY NORMAL PEPTIDE LINKS AND DERIVED FROM 5 100 AMINO ACIDS (C07K-7/04) |
| DIG 801 | DD | .~ Contains only 5-11 amino acids (C07K-7/06) |
| DIG 802 | DD | .~.~ With all amino acids in L-form (C07K-7/06A) |
| DIG 803 | DD | .~.~ With at least one amino acid in D-form (C07K-06B) |
| DIG 810 | DD | .~ Contains only 12-20 amino acids (C07K-7/08) |
| DIG 811 | DD | .~.~ With all amino acids in L-form (C07K-7/08A) |
| DIG 812 | DD | .~.~ With at least one amino acid in D-form (C07K-7/08B) |
| DIG 820 | DD | .~ Contains 21-100 amino acids (C07K-7/10) |
| DIG 821 | DD | .~.~ With all amino acids in L-form (C07K-10A) |
| DIG 822 | DD | .~.~ With at least one amino acid in D-form (C07K-7/10B) |